KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Shares Outstanding (Weighted Average) (2018 - 2025)

Historic Shares Outstanding (Weighted Average) for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $28.4 million.

  • ClearPoint Neuro's Shares Outstanding (Weighted Average) rose 302.97% to $28.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.4 million, marking a year-over-year increase of 302.97%. This contributed to the annual value of $27.0 million for FY2024, which is 984.54% up from last year.
  • According to the latest figures from Q3 2025, ClearPoint Neuro's Shares Outstanding (Weighted Average) is $28.4 million, which was up 302.97% from $28.3 million recorded in Q2 2025.
  • ClearPoint Neuro's Shares Outstanding (Weighted Average)'s 5-year high stood at $28.4 million during Q3 2025, with a 5-year trough of $18.9 million in Q1 2021.
  • For the 5-year period, ClearPoint Neuro's Shares Outstanding (Weighted Average) averaged around $24.8 million, with its median value being $24.6 million (2023).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 4323.25% in 2021, then surged by 54.11% in 2023.
  • Over the past 5 years, ClearPoint Neuro's Shares Outstanding (Weighted Average) (Quarter) stood at $20.7 million in 2021, then increased by 16.63% to $24.2 million in 2022, then grew by 1.75% to $24.6 million in 2023, then grew by 9.85% to $27.0 million in 2024, then increased by 5.18% to $28.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $28.4 million in Q3 2025, compared to $28.3 million in Q2 2025 and $27.7 million in Q1 2025.